Oligonucleotide derivatives and production thereof |
| Gist In view of the state of the art as described above, the present inventors have developed an ... |
|
Process for synthesizing macrocyclic chelates |
| The invention is a process for synthesizing a 12 membered ring tetraaza macromolecule. The process ... |
|
Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity |
| I claim: 1. A method for producing a 1:1 protein:anitbody tioether-linked immunoconjugate as a ... |
|
Compositions for photodynamic therapy |
| I claim: 1. A pharmaceutical composition useful for photodynamic therapy which composition contains,... |
|
Amplifier molecules for enhancement of diagnosis and therapy |
| As used herein, an "amplifier" or "amplifier molecule" is a chemical compound having a ... |
|
Peptide-containing polyethylene glycol derivatives and application thereof |
| OF THE PREFERRED EMBODIMENTS The present invention will hereinafter be explained in more detail. T... |
|
Modified HIL-6 |
| OF THE INVENTION Described below is the chemical modification with PEG of at least one amino group ... |
|
Construction of geometrical objects from polynucleotides |
| By means of the present invention, DNA, RNA and similar polymers may be produced by synthesizing a ... |
|
Starburst conjugates |
| In its broadest aspect, the present invention is directed to polymer conjugate materials comprising ... |
|
Intermediates for providing functional groups on the 5' end of oligonucleotides |
| We claim: 1. A partially protected alcohol of the formula: ##STR10## wherein Y.sup.1 is selected ... |
|
|
Assay for antiviral activity using complex of herpesvirus origin of replication and cellular protein
| Details |
Inventors: Schaffer, Priscilla A.; Dabrowski Amaral, Christine E.;
Assignee: Dana-Farber Cancer Institute (Boston, MA)
Primary Examiner: Mosher; Mary E.
Assistant Examiner:
Attorney, Agent or Firm: Panitch Schwarze Jacobs & Nadel, P.C.
The invention features methods and compositions useful for identifying candidate compounds for antiviral activity, useful for inhibiting replication of a DNA virus, and useful for treating an animal infected with a DNA virus. |
|
DETAILED DESCRIPTION The drawings are first described. FIG. 1 is a diagram of the HSV-1 genome and oriS. FIG. 1A indicates the locations of the three origins of DNA replication and the locations of the seven essential DNA replication genes (hatched boxes). The HSV-1 genome divided into approximate map units is also shown. FIG. 1B is a diagram of oriS indicating the location of the AT-rich region and the positions of sites I, II, and III (boxes). The DNA sequence of oriS sites I, II, III, and the AT-rich region ([SEQ. ID. NOS 12, 13, 14 and 15], respectively) is also shown. FIG. 2 is an illustration of the DNA sequences of oriS sites I, II, and III [SEQ ID NOS:12, 13, 14 and 15]. Nucleotides which have been altered compared to those present in site I DNA are shown in bold letters. FIG. 2 also contains an autoradiogram which features the relative mobilities of DNA-protein complexes formed with site I (lane 1), II (lane 2), and III (lane 3) DNA. FIG. 3 is a demonstration of competition analysis with homologous site I, II and III DNA. Cell extracts were incubated with site I, site II, and site III probes in the presence of increasing amounts of cold homologous DNA, or a 100-fold excess of non-specific (ns) DNA as competitor. (A) Gel-shift showing competition of complexes M and M'; complex M" cannot be seen in this gel because it has the same mobility as the non-specific probe. (B) Graph of the interpolated densitometric quantitation of competition analysis of the M-like complexes. Each band was scanned with an LKB Ultrascan densitometer and compared (as a percentage) to no competitor (100%). Each value represents the average of 4 to 20 experiments. FIG. 4 is a demonstration of competition analysis with site I DNA. Cell extracts were incubated with site I, site II, and site III probes in the presence of increasing amounts of cold site I DNA as competitor. The values for the graph showing competition for formation of the M-like complexes were determined as described for FIG. 3. The values represent the average of 3 to 20 experiments
|
| Related patents |
|
|
Substrate for detection of mammalian 5-C-DNA methyltransferase
OF THE INVENTION "Oligomeric DNA" or ODN, as used herein, means a DNA having from 10 to 75 "purine or pyrimidine bases" connected in a series of nucleotides which are ...
|
|
|
Vinyl ethers of nucleoside analogs
OF THE INVENTION The compounds of the present invention can exist as optical isomers. Both the racemic and diasteromeric mixtures of these isomers which may exist for ...
|
|
|
Nucleoside analogs
OF THE INVENTION The compounds of the present invention can exist as optical isomers. Both the racemic and diasteromeric mixtures of these isomers which may exist for ...
|
|
|
Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof
To accomplish those objectives, the present invention provides hydrophobic muiticomponent heparin conjugates in which heparin is coupled with macromolecules and ...
|
|
|
Gas permeable bioreactor and method of use
OF THE PREFERRED EMBODIMENTS Like numbered apparatus elements in FIGS. 1-11 are the same. Referring to the drawings, FIG. 1 is a cross-sectional side view of a ...
|
|
|
Method for treating diseases of the inner ear using adamantane derivatives
OF THE INVENTION As already mentioned, the use of adamantane derivatives is possible or conceivable in many cases of diseases of the inner ear. Preferably, adamantane ...
|
|
|
Polyalkylene oxide-containing urethane polyols with sulphonic acid groups
What is claimed is: 1. Sulphonic acid group-containing polyalkylene oxide-containing urethane polyols corresponding to the formula: ##STR16## wherein X represents an NH....
|
|
|
Herpes treatment
I claim: 1. A method for the control of herpes virus infections in man which comprises contacting the herpes lesions, topically or by injection, with a dose of L-lysine L...
|
|
|
Dense star polymers and dendrimers
OF ILLUSTRATIVE EMBODIMENTS In the dense star polymers of the present invention, the core is covalently bonded to at least one core branch, preferably at least two, ...
|
|
|
Glycerin derivatives and inhibition of blood PAF
OF THE INVENTION The glycerine derivatives of the invention are compounds of the formula ##STR3## wherein one of the residues R.sup.1, R.sup.2 and R.sup.3 is group U of ...
|
|
|